Major Ingredients

Each 5 ml oral solution contains Potassium Citrate BP 1500 mg and Citric Acid Monohydrate BP 250 mg.

Major Functionality

It is indicated to relieve discomfort in urinary tract infections due to decreased pH or acidic urine. It is also indicated in preventing kidney stone formation specially caused by uric acid with or without the presence of calcium stones and in gout therapy as a valuable adjuvant with uricosuric agents. This medicine is also effective in correcting acidosis caused by kidney disease.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.